Skip to main content

Table 4 Quality assessment of clinical trials by Jadad score

From: Administration of mesenchymal stem cells in diabetic kidney disease: a systematic review and meta-analysis

Author, year Type Randomization Concealment of allocation Double blinding Withdrawals and dropouts Jaded score
Packham et al., 2016 Multicenter, randomized, double-blind, dose-escalating, sequential, placebo-controlled trial An Interactive Voice Response System/Interactive Web Response System (IVRS/IWRS) was accessed to randomize eligible patients. All infusions were prepared by an unblinded pharmacist at the phase 1 unit who provided to the blinded clinical staff visually identical infusion products comprising rexlemestrocel-L or saline suspended in 100 mL normal saline. Patients, investigators, and the sponsor were blinded to the treatment allocation through the entire 60-week study. Yes 7